S4 Ep48: Revolutionizing Personalized Diagnostics and Global Health with Jari Närhi, Co-Founder of NADMed
This week on Tech Can’t Save Us, host Paul David is joined by Jari Närhi, Co-Founder of NADMed, a Finnish health technology company that is redefining personalized diagnostics and global health. NADMed has developed a breakthrough method for extracting and measuring nicotinamide adenine dinucleotides (NADs)—critical biomarkers for metabolic health, aging, and disease management.
They discuss how the medical landscape is transitioning from the age of genomics into the age of metabolism. Jari explains the fundamental role NADs play in cell-level metabolism and regulating hundreds of metabolic…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.